Tapentadol | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Tapentadol
US Patents

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

Contact Supplier

pharmacompass-1-m-2026-01-12

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

Contact Supplier

Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

Contact Supplier

pharmacompass-2-2026-02-09

Tapentadol

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

41 API Suppliers, 6 USDMF, 6 CEP/COS, 9 EU WC, 1 KDMF, 4 NDC API, 29 Listed Suppliers, $ API Reference Price

41 API Suppliers
6 USDMF
6 CEP/COS
9 EU WC
1 KDMF
4 NDC API
29 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

INTERMEDIATES

10 Intermediate Suppliers

10 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

268 FDF Dossiers, 32 FDA Orange Book, 169 Europe, 8 Canada, 5 Australia, 5 South Africa, 49 Listed Dossiers

268 FDF Dossiers
32 FDA Orange Book
169 Europe
8 Canada
5 Australia
5 South Africa
49 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 250MG BASE, TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE, SOLUTION;ORAL - EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 100MG BASE, TABLET;ORAL - EQ 50MG BASE, TABLET;ORAL - EQ 75MG BASE

TABLET, EXTENDED RELEASE;ORAL - EQ 100MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 150MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 200MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 250MG BASE
TABLET, EXTENDED RELEASE;ORAL - EQ 50MG BASE
SOLUTION;ORAL - EQ 20MG BASE/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 100MG BASE
TABLET;ORAL - EQ 50MG BASE
TABLET;ORAL - EQ 75MG BASE

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 1 SPI Pharma, 1 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Kirsch Pharma, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 5 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 19 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 10 Corel Pharma Chem, 5 DFE Pharma, 1 Esteem Industries, 2 Finar, 7 Gangwal Chemicals, 5 Ideal Cures, 1 Ingredion Pharma Solutions, 21 Kerry, 2 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 11 Microlex e.U, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 3 Novo Excipients, 2 Pharmatrans-Sanaq, 5 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 10 Roquette, 7 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 10 Sigachi Industries, 3 Silverline Chemicals, 2 The Dow Chemical Company, 1 Valens Pharmachem, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

44 Coating Systems & Additives, 39 Fillers, Diluents & Binders, 25 Controlled & Modified Release, 21 Granulation, 18 Thickeners and Stabilizers, 17 Direct Compression, 16 Disintegrants & Superdisintegrants, 13 Solubilizers, 12 Topical, 11 Lubricants & Glidants, 9 Film Formers & Plasticizers, 8 Co-Processed Excipients, 7 Taste Masking, 6 Parenteral, 5 Empty Capsules, 4 Chewable & Orodispersible Aids, 4 Vegetarian Capsules, 4 API Stability Enhancers, 4 Emulsifying Agents, 3 Rheology Modifiers, 2 Coloring Agents

44 Coating Systems & Additives
39 Fillers, Diluents & Binders
25 Controlled & Modified Release
21 Granulation
18 Thickeners and Stabilizers
17 Direct Compression
16 Disintegrants & Superdisintegrants
13 Solubilizers
12 Topical
11 Lubricants & Glidants
9 Film Formers & Plasticizers
8 Co-Processed Excipients
7 Taste Masking
6 Parenteral
5 Empty Capsules
4 Chewable & Orodispersible Aids
4 Vegetarian Capsules
4 API Stability Enhancers
4 Emulsifying Agents
3 Rheology Modifiers
2 Coloring Agents

DIGITAL CONTENT

39 News #PharmaBuzz

39 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 16 Regulatory FDF Prices

2 US Medicaid Prescriptions
16 Regulatory FDF Prices

MARKET PLACE

26 APIs, 2 FDF Dossiers

26 APIs
2 FDF Dossiers

PATENTS & EXCLUSIVITIES

25 US Patents, 8 US Exclusivities, 67 Health Canada Patents

25 US Patents
8 US Exclusivities
67 Health Canada Patents

$ API Ref.Price (USD/KG) : 582 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

25 All

01 25COLLEGIUM PHARM INC

filter Patent Number Reset all filters

25 All

01 58536130

02 1011344512

03 511344512*PED

04 58536130*PED

API Patent Reset all filters

25 All

01 25Blank

FDF Patent Reset all filters

25 All

01 25Blank

filter Expiration Date Reset all filters

25 All

01 102028-04-21

02 52028-09-22

03 52028-10-21

04 52029-03-22

Product Main Page

01

COLLEGIUM PHARM INC

TAPENTADOL HYDROCHLORIDE

euroPLX 90 Lisbon

Not Confirmed

COLLEGIUM PHARM INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-09-22

TAPENTADOL HYDROCHLORIDE

US Patent Number : 8536130

Drug Substance Claim :

Drug Product Claim :

Application Number : 200533

Patent Use Code : U-1276

Delist Requested :

Patent Use Description : MANAGEMENT OF NEUROPAT...

Patent Expiration Date : 2028-09-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

COLLEGIUM PHARM INC

TAPENTADOL HYDROCHLORIDE

euroPLX 90 Lisbon

Not Confirmed

COLLEGIUM PHARM INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-09-22

TAPENTADOL HYDROCHLORIDE

US Patent Number : 8536130

Drug Substance Claim :

Drug Product Claim :

Application Number : 200533

Patent Use Code : U-1276

Delist Requested :

Patent Use Description : MANAGEMENT OF NEUROPAT...

Patent Expiration Date : 2028-09-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

COLLEGIUM PHARM INC

TAPENTADOL HYDROCHLORIDE

euroPLX 90 Lisbon

Not Confirmed

COLLEGIUM PHARM INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-09-22

TAPENTADOL HYDROCHLORIDE

US Patent Number : 8536130

Drug Substance Claim :

Drug Product Claim :

Application Number : 200533

Patent Use Code : U-1276

Delist Requested :

Patent Use Description : MANAGEMENT OF NEUROPAT...

Patent Expiration Date : 2028-09-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

COLLEGIUM PHARM INC

TAPENTADOL HYDROCHLORIDE

euroPLX 90 Lisbon

Not Confirmed

COLLEGIUM PHARM INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-09-22

TAPENTADOL HYDROCHLORIDE

US Patent Number : 8536130

Drug Substance Claim :

Drug Product Claim :

Application Number : 200533

Patent Use Code : U-1276

Delist Requested :

Patent Use Description : MANAGEMENT OF NEUROPAT...

Patent Expiration Date : 2028-09-22

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

COLLEGIUM PHARM INC

TAPENTADOL HYDROCHLORIDE

euroPLX 90 Lisbon

Not Confirmed

COLLEGIUM PHARM INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-04-21

TAPENTADOL HYDROCHLORIDE

US Patent Number : 11344512

Drug Substance Claim :

Drug Product Claim :

Application Number : 200533

Patent Use Code : U-3391

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-04-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

COLLEGIUM PHARM INC

TAPENTADOL HYDROCHLORIDE

euroPLX 90 Lisbon

Not Confirmed

COLLEGIUM PHARM INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-04-21

TAPENTADOL HYDROCHLORIDE

US Patent Number : 11344512

Drug Substance Claim :

Drug Product Claim :

Application Number : 200533

Patent Use Code : U-3392

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-04-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

COLLEGIUM PHARM INC

TAPENTADOL HYDROCHLORIDE

euroPLX 90 Lisbon

Not Confirmed

COLLEGIUM PHARM INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-04-21

TAPENTADOL HYDROCHLORIDE

US Patent Number : 11344512

Drug Substance Claim :

Drug Product Claim :

Application Number : 200533

Patent Use Code : U-3392

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-04-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

COLLEGIUM PHARM INC

TAPENTADOL HYDROCHLORIDE

euroPLX 90 Lisbon

Not Confirmed

COLLEGIUM PHARM INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-04-21

TAPENTADOL HYDROCHLORIDE

US Patent Number : 11344512

Drug Substance Claim :

Drug Product Claim :

Application Number : 200533

Patent Use Code : U-3392

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-04-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

COLLEGIUM PHARM INC

TAPENTADOL HYDROCHLORIDE

euroPLX 90 Lisbon

Not Confirmed

COLLEGIUM PHARM INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-04-21

TAPENTADOL HYDROCHLORIDE

US Patent Number : 11344512

Drug Substance Claim :

Drug Product Claim :

Application Number : 200533

Patent Use Code : U-3392

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-04-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

COLLEGIUM PHARM INC

TAPENTADOL HYDROCHLORIDE

euroPLX 90 Lisbon

Not Confirmed

COLLEGIUM PHARM INC

euroPLX 90 Lisbon

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2028-04-21

TAPENTADOL HYDROCHLORIDE

US Patent Number : 11344512

Drug Substance Claim :

Drug Product Claim :

Application Number : 200533

Patent Use Code : U-3392

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2028-04-21

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.